POSTER: AML-132 QuANTUM-First Trial: FLT3–Internal Tandem Duplication (FLT3-ITD)–Specific Measurable Residual Disease (MRD) Clearance Is Associated With Improved Overall Survival (OS)
Clinical Lymphoma, Myeloma & Leukemia（2023）
Key words
acute myeloid leukemia,FLT3-ITD,measurable residual disease,NGS,PCR,quizartinib,phase III
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined